The study to evaluate the efficacy and safety of Polynucleotide on Acne Scars

Phase 4

Recruiting

• Conditions: Acne scar; Polynucleotide, Acne scar

• Registration Number: TCTR20230213003
• Lead Sponsor: SW HEALTHCARE CO.,LTD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-13
• Study Completion: 2023-10-16
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

1. Aged 18-60 years old
2. Both male and female
3. moderate to severe acne scar from global acne scar grading system

Exclusion Criteria

1. Subjects who are pregnant
2. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin
3. Subjects who has dermatits, wound or infection at treatment area
4. Subjects who allergy to anesthesia cream
5. Subjects who taken oral or injection contraceptive pills
6. Subjects who had history of laser, filler and botox at treatment area within 12 months before arrived the project
7. Subjects who had history of keloid or hypertrophic scar
8. Subjects who had history of psychitic disease
9. Subjects who use tretinoin or AHA with in 1 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified